SCHEMBL19994497

SCHEMBL19994497

CN(C(=O)c1ccc2[nH]cnc2c1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.49
KMT2A Q03164 2/20 0.49
PLAU P00749 1/20 0.48
HTT P42858 3/20 0.48
ALDH1A1 P00352 3/20 0.48
RAB9A P51151 3/20 0.48
HPGD P15428 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
NPC1 O15118 2/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
ALOX12 P18054 1/20 0.46
CYP2C19 P33261 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MEN1 O00255 1/20 0.45
MAOA P21397 2/20 0.45
KDM1A O60341 1/20 0.45
MAOB P27338 1/20 0.45
CTNNB1 P35222 1/20 0.45
WNT3A P56704 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5142596 0.91 HSD17B2 (0.50) KDM4EKMT2APLAUHTTALDH1A1
SCHEMBL30069113 0.89 RAB9A (0.62) KDM4EKMT2APLAUHTTALDH1A1
SCHEMBL19994498 0.89 RAB9A (0.62) KDM4EKMT2APLAUHTTALDH1A1
SCHEMBL6445178 0.84 MEN1 (0.54) KDM4EKMT2AHTTALDH1A1RAB9A
SCHEMBL3727867 0.83 HDAC6 (0.45) KDM4EKMT2AHTTALDH1A1RAB9A
SCHEMBL19183584 0.81 RAB9A (0.43) KDM4EKMT2AHTTALDH1A1RAB9A
SCHEMBL13373337 0.81 KMT2A (0.58) KMT2AHTTALDH1A1HPGDMEN1
SCHEMBL1249135 0.78 KDM4E (0.49) KDM4EKMT2APLAUHTTALDH1A1
SCHEMBL6112686 0.78 KMT2A (0.41) KDM4EKMT2AHTTALDH1A1RAB9A
SCHEMBL1801614 0.77 ALDH1A1 (0.77) KDM4EKMT2AHTTALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3515904-A1 BENZOIMIDAZOLE DERIVATIVES AS ANTICANCER AGENTS Centre Leon Berard (FR) 2019-07-31 EP disclosed
WO-2018054989-A1 BENZOIMIDAZOLE DERIVATIVES AS ANTICANCER AGENTS CENTRE LEON BERARD (FR) 2018-03-29 WO disclosed